Tuesday, November 26, 2024

Re: [EXTERNAL] Re: Invitation to speak at the MD Anderson Virtual Data Science Forum

TITLE:

Topics in Cancer Genomics

ABSTRACT:

My talk will cover material from the following papers:

Using sigLASSO to optimize cancer mutation signatures jointly with
sampling likelihood.
S Li, FW Crawford, MB Gerstein (2020). Nat Commun 11: 3575.

Latent Evolutionary Signatures: A General Framework for Analyzing
Music and Cultural Evolution
J Warrell, L Salichos, M Gancz, MB Gerstein (2024). J R Soc Interface
21: 20230647.

Assessing and mitigating privacy risks of sparse, noisy genotypes by
local alignment to haplotype databases.
PS Emani, MN Geradi, G Gursoy, MR Grasty, A Miranker, MB Gerstein
(2023). Genome Res 33: 2156-2173.

Unified views on variant impact across many diseases
S Kumar, M Gerstein (2023). Trends Genet 39: 442-450.

Passenger Mutations in More Than 2,500 Cancer Genomes: Overall
Molecular Functional Impact and Consequences.
S Kumar, J Warrell, S Li, PD McGillivray, W Meyerson, L Salichos, A
Harmanci, A Martinez-Fundichely, CWY Chan, MM Nielsen, L Lochovsky, Y
Zhang, X Li, S Lou, JS Pedersen, C Herrmann, G Getz, E Khurana, MB
Gerstein (2020). Cell 180: 915-927e16.

Origins and characterization of variants shared between databases of
somatic and germline human mutations.
W Meyerson, J Leisman, FCP Navarro, M Gerstein (2020). BMC
Bioinformatics 21: 227.

i0md24

No comments: